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Abstract:  
Mitochondrial dysfunction contributes to cardiac ischemia–reperfusion 
(IR) injury but volatile anesthetics (VA) may alter mitochondrial function to 
trigger cardioprotection. We hypothesized that the VA isoflurane (ISO) 
mediates cardioprotection in part by altering the function of several 
respiratory and transport proteins involved in oxidative phosphorylation 
(OxPhos). To test this we used fluorescence spectrophotometry to measure 
the effects of ISO (0, 0.5, 1, 2 mM) on the time-course of interlinked 
mitochondrial bioenergetic variables during states 2, 3 and 4 respiration in 
the presence of either complex I substrate K+-pyruvate/malate (PM) or 
complex II substrate K+-succinate (SUC) at physiological levels of extra-
matrix free Ca2 + (~ 200 nM) and Na+ (10 mM). To mimic ISO effects on 
mitochondrial functions and to clearly delineate the possible ISO targets, the 
observed actions of ISO were interpreted by comparing effects of ISO to 
those elicited by low concentrations of inhibitors that act at each respiratory 
complex, e.g. rotenone (ROT) at complex I or antimycin A (AA) at complex 
III. Our conclusions are based primarily on the similar responses of ISO and 
titrated concentrations of ETC. inhibitors during state 3. We found that with 
the substrate PM, ISO and ROT similarly decreased the magnitude of state 3 
NADH oxidation and increased the duration of state 3 NADH oxidation, ΔΨm 
depolarization, and respiration in a concentration-dependent manner, 
whereas with substrate SUC, ISO and ROT decreased the duration of state 3 
NADH oxidation, ΔΨm depolarization and respiration. Unlike AA, ISO reduced 
the magnitude of state 3 NADH oxidation with PM or SUC as substrate. With 
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substrate SUC, after complete block of complex I with ROT, ISO and AA 
similarly increased the duration of state 3 ΔΨm depolarization and respiration. 
This study provides a mechanistic understanding in how ISO alters 
mitochondrial function in a way that may lead to cardioprotection. 
Keywords: Volatile anesthetic; Isoflurane; Mitochondrial bioenergetics; 
Electron transport chain; Cardiac IR injury; Cardioprotection 
1. Introduction 
Mitochondria are primary mediators of cardiac ischemia–
reperfusion (IR) injury [1], [2], [3] and [4]; they are also important 
targets for volatile anesthetic (VA)-induced cardioprotection against IR 
injury [3], [5], [6], [7], [8], [9], [10], [11] and [12]. Cardioprotection 
by a VA can be instituted either before the onset of ischemia 
(anesthetic pre-conditioning: APC) or at the onset of reperfusion 
(anesthetic post-conditioning: APOC) [13] and [14]. Regardless of the 
cardioprotective strategy, VAs exert effects on mitochondrial function. 
Mitochondrial failure consequent to bioenergetic dysfunction 
leads to cell damage during IR but specific components of the 
mitochondrial bioenergetic mechanisms may be targets for the actions 
of VAs that underlie APC or APOC against IR injury. Volatile 
anesthetics, including isoflurane (ISO) are known to mediate 
cardioprotection against IR injury, in part, by attenuating function of 
the electron transport chain (ETC) protein complex I (NADH 
oxidoreductase) and by triggering mild ROS production, a critical 
mediator for cellular protection [15], [16], [17] and [18]. The 
mechanisms of ISO and other VAs to alter mitochondrial function and 
confer cardioprotection via their actions on ETC complexes and other 
mitochondrial transport proteins, however, are not well understood. 
It may seem incongruous at first that IR-induced injury 
ultimately leads to dysfunction of mitochondrial respiration but, on the 
other hand, attenuation of mitochondrial respiration might minimize 
mitochondrial injury and reduce cell death during cardiac IR injury 
[19] and [20]. Thus, an understanding of ISO-induced actions on 
selective mitochondrial proteins, including the ETC complexes and 
transport proteins that are crucial for oxidative phosphorylation 
(OxPhos), is essential in elucidating the mechanisms of ISO-induced 
cardioprotection against IR injury. 
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In our recent study in isolated mitochondria [8] in which we 
demonstrated that ISO attenuates Ca2 + extrusion by the mitochondrial 
Na+/Ca2 + exchanger, we also found that ISO caused a concentration-
dependent decrease in the rate of state 3 NADH oxidation and ADP 
phosphorylation with the complex I substrate pyruvate/malate (PM). 
Complex I was first suggested as a site for VA effects [21] and [22]; 
this was supported by later findings [23] and [24]. Our initial observed 
effects of ISO [8] to increase the duration of state 3 NADH oxidation 
and ΔΨm depolarization also supported complex I as a site of action, 
but this could alternatively have been due to inhibition of other ETC. 
complexes downstream of complex I, e.g., complexes III (ubiquinol 
cytochrome c oxidoreductase), IV (cytochrome c oxidase) and V (F1F0 
ATP synthase), or complex II (succinate dehydrogenase) and transport 
proteins (e.g. adenine nucleotide transporter, ANT); alternatively, as 
has been reported, ISO might act as an uncoupling agent by 
promoting a proton leak [25] that could lead to mild ΔΨm 
depolarization. 
Because our understanding of the mechanisms of ISO-targeted 
mitochondrial interventions is not well defined, we compared the ISO 
effects to those elicited by low concentrations of known site-specific 
inhibitors of mitochondrial proteins. That is, we explored the potential 
mitochondrial targets of ISO by comparing its concentration-
dependent effects with the concentration-dependent effects of known 
inhibitors of ETC. complexes and mitochondrial transport proteins to 
identify, and also rule out, possible ISO targets. In this way we hoped 
to better understand how VA-induced modification of mitochondrial 
bioenergetics can contribute to cardioprotection. To carry out our aims 
we used isolated cardiac mitochondria energized with substrates K+-
pyruvate/malate (PM), K+-succinate (SUC) or SUC + Rotenone (ROT, 
1 μM). Low concentrations of ROT antimycin A (AA), oligomycin 
(OMN), and atractyloside (ATR) were used to stepwise attenuate 
complexes I, III, V and ANT function, respectively; low concentrations 
of malonate (MAL) and potassium cyanide (KCN) were used in some 
experiments to attenuate functions of complexes II and IV, 
respectively. 
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2. Materials and methods 
2.1. Mitochondrial isolation 
Mitochondria were freshly isolated from hearts of Wistar rats 
(300–350 g) using protocols approved by the Medical College of 
Wisconsin Institutional Animal Care and Use Committee (IACUC) as 
described previously [8]. Briefly, rats were anesthetized with an 
intraperitoneal injection of inactin (150 mg/kg), and the ventricles 
were excised and placed in an ice-cold isolation buffer that contained 
(in mM): 200 mannitol, 50 sucrose, 5 KH2PO4, 5 MOPS, 1 EGTA and 
0.1% BSA, with pH adjusted to 7.15 with KOH. The ventricles were 
minced in the presence of 5 U/ml protease (Bacillus licheniformis, 
Sigma) followed by differential centrifugation. All isolation procedures 
were carried out at 4 °C. Mitochondrial protein content was 
determined by the Bradford method [26]. The final mitochondrial 
pellet was resuspended in isolation buffer and kept on ice. All 
chemicals were procured from Sigma (St. Louis, MO, USA), unless 
stated otherwise. 
2.2. Measure of mitochondrial redox state (NADH) 
NADH autofluorescence was measured in the mitochondrial 
suspension during states 2, 3 and 4 respiration using fluorescence 
spectrophotometry at excitation wavelength 350 nm and emission 
wavelengths 395 nm and 456 nm (Photon Technology International, 
Birmingham, NJ), as we have described before [8], [27], [28], 
[29] and [30]. At the end of each experiment (390 s), maximal (fully 
reduced) NADH (high NADH/NAD+) was determined with 1 μM ROT, 
which completely blocks electron transport via FeS centers in complex 
I at the ubiquinone (Q) binding site so that proton pumping from 
NADH cannot occur; minimal (fully oxidized) NADH (low NADH/NAD+) 
was determined with 20 μM trifluorocarbonylcyanidephenylhydrazone 
(FCCP), which induces maximal proton leak, and causes an increase in 
proton pumping and electron transfer between ETC complexes. The 
ratio of emission fluorescence (456/395) was normalized between the 
fully oxidized (with FCCP) state to the fully reduced (with ROT) state to 
represent % NADH as the total pool of NADH + NAD+. 
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2.3. Measure of mitochondrial membrane potential 
(ΔΨm) 
ΔΨm was measured in the mitochondrial suspension during 
states 2, 3 and 4 respiration by fluorescence spectrophotometry using 
the fluorescent dye tetramethyl-rhodamine methyl ester (1 μM TMRM; 
Molecular Probes, Eugene, OR) at excitation wavelengths 546 nm and 
573 nm and emission wavelength 590 nm [31], as we have described 
[29]. TMRM is a ratiometric, membrane potential sensitive, cationic 
fluorophore that equilibrates across the inner mitochondrial membrane 
(IMM) based on its electrochemical potential. ΔΨm measurements 
followed the same time-line protocol as NADH measurements except 
that the respiratory uncoupler carbonyl cyanide m-
chlorophenylhydrazone (4 μM CCCP) was used to fully depolarize ΔΨm. 
The ratio of excitation wavelengths (546/573) at any time point was 
plotted as a percent of maximum fluorescence (100%) obtained by 
maximal depolarization with CCCP. 
2.4. Measure of mitochondrial O2 consumption 
Mitochondrial O2 consumption rate (respiration) was measured 
using a Clark-type O2 electrode (System S 200A; Strathkelvin 
Instruments, Glasgow, UK) as we have described before [8], [30], 
[32] and [33]. Functional integrity of mitochondria was determined by 
the respiratory control index (RCI), defined here as the ratio of state 3 
(after added ADP) to state 4 respiration (after complete 
phosphorylation of the added ADP). Only mitochondrial preparations 
with RCIs ≥ 6, measured with PM, were used to conduct further 
experiments. 
2.5. Protocol 
Measures of the three bioenergetic variables (NADH, ΔΨm, and 
respiration) were conducted with mitochondria (0.5 mg/ml) suspended 
in respiration buffer that contained (in mM): 130 KCl, 10 NaCl, 0.5 
CaCl2, 5 K2HPO4, 20 MOPS, 1 EGTA and 0.1% BSA at pH 7.15 adjusted 
with KOH, at room temperature (25 °C). NADH, ΔΨm, and respiration 
were monitored under complex I-linked substrate (10 mM PM) or 
complex II-linked substrate (10 mM SUC) during respiratory states 2 
(before adding ADP), 3 (during phosphorylation of 250 μM ADP), and 4 
(after complete phosphorylation of the ADP). Along with drug free 
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controls (0.1% DMSO), either of three concentrations of ISO (0.5, 1, 
2 mM) or several titrated low concentrations of respiratory complex 
inhibitors (e.g. 30, 50, 80, 120, 150 nM ROT; 25, 75, 85, 100, 110 nM 
AA) were added to the buffer after adding the substrate, followed by 
ADP. All drugs were dissolved in DMSO (0.1%). The appropriate 
volumes of ISO stock solutions dissolved in DMSO were prepared in 
tightly sealed glass vials and specific volumes from these vials were 
added to the experimental buffer (1 ml) to obtain the desired ISO 
concentrations (i.e. 0.5, 1 and 2 mM). ISO, 0.5 mM, is equivalent to 
approximately 1.4% atm at 25 °C with an estimated 1.3 minimum 
alveolar concentration (MAC) for rats [23]. To confirm the actual 
concentrations of ISO in each mitochondrial suspension, an aliquot of 
isoflurane in solution from each vial was obtained and measured by 
gas chromatography at the beginning (100 s) and end of each 
experiment (500 s). For added ISO, the measured values varied within 
± 10% of their initial prepared values of 0.5, 1, 1.5 and 2 mM. The 
time-course protocol consisted of the following: (1) 0 s, addition of 
mitochondrial sample into the respiration buffer and start of recording; 
(2) 30 s, introduction of the substrate (PM or SUC or SUC + ROT) 
(1 μM; high concentration that completely blocks electron flow from 
complex I) (state 2); (3) 90 s, addition of either of DMSO, ISO or 
other mitochondrial protein inhibitors, and (4) 150 s, addition of ADP 
(state 3). 
Adding substrate PM or SUC provided for forward electron 
transfer from complex I or II through complex IV, respectively, and 
only reverse electron transfer from complex II to I with SUC. Substrate 
SUC with a complete block of complex I by ROT (1 μM) allowed for 
forward electron transfer only from complex II through IV. Sites of 
inhibition by blockers of each of the five respiratory complexes, and 
ANT, as well as how modulation of ΔΨm and matrix pH are all involved 
in OxPhos are shown schematically (Fig. 1). 
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Fig. 1. Schema depicting the mitochondrial electron transport chain (ETC) protein 
complexes of the mitochondrial inner membrane (IMM), along with their specific 
inhibitors: rotenone (ROT), malonate (MAL), antimycin A (AA), potassium cyanide 
(KCN), oligomycin (OMN), and atractyloside (ATR). Reducing equivalents, NADH and 
FADH2, are generated via the tricarboxylic acid (TCA) cycle in the matrix, while 
electrons are transferred through the complexes to the final O2 acceptor. At complex 
IV, coupled with this transfer is the pumping of protons (H+) into the intermembrane 
space (IMS) by complex I, complex III, and complex IV, which generate the H+ 
gradient used by ATP synthase (complex V) to phosphorylate ADP to ATP. Depending 
on the substrate used, K+-pyruvate/malate (PM) or K+-succinate (SUC), isolated 
mitochondria respire differentially using NADH and FADH2 to produce ATP; this is 
coupled to forward or reverse electron transfer (FET or RET) depending on the 
reduction potential across each complex and across the IMM. ( ) represents potential 
targets of isoflurane (ISO) on the ETC. components explored in this study. 
2.6. Data analysis and statistics 
Traces are representative of the mean of three different 
mitochondrial preparations, each with three replicate recordings. 
Where appropriate, data are represented as mean ± SD of three 
independent experiments. All data were compiled using Microsoft Excel 
and analyzed using one-way ANOVA (analysis of variance) with 
Turkey's post-hoc test for significance of means. Differences with 
P < 0.05 (two-tailed) were considered significant. 
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3. Results 
3.1. Effect of isoflurane vs. respiratory inhibitors on 
mitochondrial redox state (NADH) 
Time-dependent effects of DMSO (vehicle) and graded 
concentrations of ISO, complex I (ROT), or complex III (AA) inhibitors 
in the presence of the substrate PM or SUC during states 2, 3 and 4 
are shown in Fig. 2A–F. The insets show summaries of their effects on 
the duration of ADP-induced state 3 NADH oxidation (S3 time, s). ISO, 
ROT, and AA each had no effect on resting state 2 NADH. With the 
complex I substrate PM, ISO caused pronounced concentration-
dependent decreases in state 3 NADH oxidation with respect to state 2 
NADH after adding ADP: 32 ± 7%, 27 ± 5% and 21 ± 5% at 0.5, 1 
and 2 mM ISO, respectively, vs. 42 ± 4% with DMSO. ISO also 
significantly increased the duration of state 3 NADH oxidation: 
50 ± 4 s, 66 ± 6 s and 103 ± 8 s at 0.5, 1 and 2 mM, respectively, vs. 
41 ± 5 s for DMSO (Fig. 2A inset). 
To deduce if ISO decreased state 3 NADH oxidation by an action 
on complex I, the changes in NADH induced by ISO during state 3 with 
substrate PM were compared to the effects of titrated, low 
concentrations of the complex I inhibitor ROT (Fig. 2B). These data 
showed, similar to ISO, that ROT attenuated the magnitude of state 3 
NADH oxidation in a concentration-dependent manner: 35 ± 5%; 
25 ± 6%; and 14 ± 4% at 20, 30 and 50 nM, respectively, vs. 
41 ± 4% for DMSO. Also like ISO, ROT caused a concentration-
dependent increase in the duration of state 3 NADH oxidation (Fig. 2B 
inset). 
To determine if ISO-induced increases in the duration of state 3 
NADH oxidation might also result from reduced proton pumping and 
electron transfer downstream from complex I, NADH oxidation was 
assessed with titrated, low concentrations of the complex III blocker 
AA (see Fig. 1). AA caused concentration-dependent increases in the 
duration of state 3 NADH oxidation (Fig. 2C; inset), but unlike ISO and 
ROT, it did not decrease the magnitude of state 3 NADH oxidation. 
These data indicated that with PM as substrate, ISO decreased the 
extent and increased the duration of state 3 NADH oxidation similar to 
that of ROT, while it only increased the duration of state 3 NADH 
oxidation similar to that of AA. This indicated that both complexes I 
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and III might be functional targets for ISO to retard restoration of the 
redox state (Fig. 7A). 
 
 
Fig. 2.  Normalized mitochondrial redox state (NADH/NADH + NAD+) during states 
2, 3 and 4 respiration with different substrates and either ISO or a blocker of ETC 
complexes. State 2 was induced with 10 mM PM (A–C) or SUC (D–F) and state 3 with 
250 μM ADP; state 4 is after phosphorylation of all ADP to ATP. ISO, ROT, or AA was 
added after PM or SUC and before ADP. ADP induced a transient decrease in the 
reduced state of NADH. The insets summarize effects of ISO compared to ROT and AA 
on duration of ADP-induced state 3 NADH oxidation (S3 time, s). Note similarities and 
differences of responses to each drug. NADH transients were normalized on a scale of 
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0–1, i.e. between fully oxidized to fully reduced states by adding excess FCCP or ROT, 
respectively. Data represent mean ± SD of 3 replicates. 
To test if the ISO-induced changes in the extent and duration of 
state 3 NADH oxidation could also result from reduced inward 
translocation of ADP in exchange for ATP extrusion (Fig. 1), NADH 
oxidation was measured with low concentrations (0.25 to 1 μM) of the 
ANT inhibitor, ATR. But, unlike ISO, ATR caused concentration-
dependent decreases in both the extent and duration of state 3 NADH 
oxidation (data not shown); together these findings suggested that 
there was reduced ADP entry and availability during state 3 to oxidize 
NADH. The complex IV blocker KCN at low titrated concentrations (up 
to 1 μM) did not exhibit effects similar to ISO on any of the 
mitochondrial bioenergetic variables with any substrate tested (data 
not shown). 
We tested further if the prolonged effects of ISO on the duration 
of NADH oxidation with the substrate PM during state 3 were different 
from those elicited by the complex II substrate SUC (Fig. 2D) and how 
these responses compared with the effects of 30–150 nM ROT 
(Fig. 2E) or 100 and 125 nM AA (Fig. 2F). With the substrate SUC, 
adding ADP prolonged the duration of NADH oxidation substantially 
more than with the substrate PM (Fig. 2D vs. A). ISO tended to only 
slightly reduce the magnitude of oxidation but to markedly decrease 
the duration of NADH oxidation (Fig. 2D inset). Because ROT 
attenuates both forward and reverse electron transfer through 
complex I, enhancing attenuation of proton pumping and electron 
transfer by ROT or ISO leads to less oxidation of NADH during state 3. 
ROT had a greater effect than ISO on both the extent and duration of 
NADH oxidation (Fig. 2E vs. D) suggesting that ISO may attenuate 
complex I function somewhat differently than ROT, which blocks 
electron transfer via a FeS centers at the Q binding site in complex I. 
In contrast to the effects of ISO and ROT on attenuating state 3-
induced oxidation of NADH with the substrate SUC, AA did not change 
the extent or duration of NADH oxidation (Fig. 2F) when compared to 
DMSO. Thus, these results suggested that ISO-induced effects on 
NADH redox state were mediated by attenuating complex I electron 
transfer, which in turn impeded proton pumping by NADH. 
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3.2. Effect of isoflurane vs. respiratory inhibitors on 
mitochondrial membrane potential (ΔΨm) 
Time-dependent effects of DMSO (vehicle) and graded 
concentrations of ISO, complex I (ROT), or complex III (AA) inhibitors 
on ΔΨm in the presence of PM or SUC during respiratory states 2, 3 
and 4 are shown in Fig. 3A–F. The insets show summaries of their 
effects on the duration of ADP-induced depolarization of ΔΨm (S3 time, 
s). ISO, ROT and AA had no effect on resting state 2 ΔΨm. Adding ADP 
caused a sudden, partial, and reversible ΔΨm depolarization in all 
groups because of the transiently smaller charge and pH gradients 
across the IMM due to the stimulation of respiration. With the complex 
I substrate, PM, ISO significantly increased the duration of state 3 
depolarization of ΔΨm, i.e. by 45 ± 4 s, 81 ± 7 s and 133 ± 7 s at 0.5, 
1 and 2 mM, respectively, vs. 38 ± 3 s for DMSO (Fig. 3A). With the 
substrate PM, compared to DMSO, adding ADP after ISO, ROT, or AA 
caused a delay in state 3 ΔΨm repolarization (Fig. 3A,B,C). 
Like ISO, ROT had similar effects on the duration of state 3 ΔΨm 
depolarization (Fig. 3A,B insets) and NADH oxidation (Fig. 2A,B insets) 
and on the increase in the magnitude of state 3 ΔΨm depolarization; 
this was likely due to attenuation of complex I electron transfer and 
proton pumping during state 3. Like ISO (Fig. 3A inset), ROT and AA 
caused concentration-dependent increases in the duration of state 3 
ΔΨm depolarization (Fig. 3B,C insets). The observed ISO-induced 
increases in the extent and the duration of state 3 ΔΨm depolarization 
(Fig. 3A) were consistent with the observed ISO-induced decrease in 
the extent and increase in the duration of state 3 NADH oxidation 
(Fig. 2A). 
Unlike ISO with the substrate PM, and as observed with NADH, 
ATR (0.5–1 μM) caused a concentration-dependent attenuation of the 
ADP-induced decrease in ΔΨm, likely due to reduced ADP translocation 
through ANT (data not shown); Thus, the marked differences in ISO 
and ATR responses suggested again that the effects of ISO were not 
mediated via ANT. 
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Fig. 3.  Normalized mitochondrial membrane potential (ΔΨm) during states 2, 3 and 
4 respiration with different substrates and after adding either ISO or a blocker of ETC 
complexes. ISO, ROT, or AA was given after PM (A–C) or SUC (D–F), and before ADP, 
which induced a transient depolarization. The insets summarize effects of ISO 
compared to ROT and AA on duration of ADP-induced state 3 decreases in ΔΨm (S3 
time, s). Note similarities and differences of responses to each drug. ΔΨm transients 
were normalized with respect to maximal (100%) depolarization obtained with added 
CCCP. Data represent mean ± SD of 3 replicates. 
 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biochimica et Biophysica Acta: Bioenergetics, Vol 1837, No. 3 (March 2014): pg. 354-365. DOI. This article is © Elsevier 
and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant 
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from 
Elsevier. 
14 
 
Similar to the NADH measurements (Fig. 2), we also compared 
the effects of ISO, ROT, and AA (Fig. 3D,E,F), respectively, on 
changing the extent and duration of ΔΨm depolarization in the 
presence of the complex II substrate SUC during states 2, 3 and 4. 
ISO, ROT and AA had no effects on resting state 2 ΔΨm. Adding ADP in 
the ISO and ROT groups caused small decreases in the magnitude of 
ΔΨm depolarization (Fig. 3D,E) and significant concentration-
dependent decreases in the duration of state 3 ΔΨm (Fig. 3D,E insets). 
In contrast, AA caused concentration-dependent increases in the 
duration of ADP-induced ΔΨm depolarization (Fig. 3F and inset). The 
similarity of the concentration-dependent effects of ISO vs. ROT and 
AA (Fig. 3A–C) on the duration of the transient ΔΨm depolarization 
during state 3 duration (Fig. 3A inset) with NADH-linked substrate PM 
supports the notion that complexes I and III are targets for attenuated 
mitochondrial function by ISO. In contrast, giving AA in the presence 
of SUC did not mimic the effects of ISO on the duration of state 3 ΔΨm 
depolarization (Fig. 3D vs. 3 F). 
Because the state 3 effects on the duration of ΔΨm 
depolarization for ISO were similar to those of ROT, but somewhat 
dissimilar to AA in the presence of substrate SUC (Fig. 3D vs. E and F), 
we conducted additional experiments in which complex I was 
completely blocked by 1 μM ROT before adding SUC; this was followed 
by addition of ISO or AA. Under these conditions both ISO and AA 
caused increases in the duration of ADP-induced ΔΨm depolarization, 
which re-affirmed that ISO has inhibitory effects on complex III 
(Fig. 4A,B). In this scenario it was likely that ISO, like AA, exerted 
similar effects to inhibit complex III when SUC was the substrate with 
complete inhibition of reverse electron transfer (RET) before adding 
SUC. When ISO (or AA) was added, the duration of ΔΨm depolarization 
increased because of slowed forward electron transfer (FET) to 
complex IV from complex III (Fig. 1 and Fig. 7C). This slowing led to 
the increases in the duration of state 3 ΔΨm depolarization. 
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Fig. 4. Normalized mitochondrial membrane potential (ΔΨm) during states 2, 3 and 
4 respiration with SUC + ROT and either ISO or a blocker of ETC. ROT (1 μM) was 
given before other drugs to maximally block complex I. ISO (A), AA (B), MAL (C), or 
ATR (D) was added after SUC (A–D) and before adding ADP, which induced a transient 
depolarization. The insets summarize effects of ISO compared to AA, MAL, and ATR on 
duration of state 3 ADP-induced decreases in ΔΨm (S3 time, s). Note similarities and 
differences of responses to each drug. ΔΨm transients were normalized with respect to 
maximal (100%) depolarization obtained with added CCCP. Data represents 
mean ± SD of 3 replicates. 
However, it remained possible that ISO could also slow electron 
transport at complex II since this was another site of electron 
generation with SUC as the substrate. With complex I completely 
blocked by ROT, and SUC as the only substrate, adding the complex II 
inhibitor MAL (50–200 nM) resulted in only slight but not significant 
increases in maximal state 3 ΔΨm depolarization (Fig. 4C) and state 3 
duration (Fig. 4C inset). Because this is unlike the response of ISO to 
the increased state 3 duration, we concluded that ISO has no 
demonstrable effects on complex II. 
We also examined if ANT is sensitive to ISO when complex I is 
first blocked by ROT before adding the substrate SUC. Under 
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conditions of SUC + ROT (1 μM), ISO increased the duration of state 3 
ΔΨm; therefore we explored the possibility that this may result in part 
from a decreased rate of ADP phosphorylation by attenuation of ANT 
for translocation of ADP for ATP. With titrated low concentrations of 
ATR (150 nM–3 μM), there was a concentration dependent decrease in 
ADP-induced state 3 ΔΨm depolarization (Fig. 4D); but there was no 
significant change in the duration of ADP phosphorylation because of 
lesser exchange of ADP for ATP compared to the DMSO (vehicle) 
group. The effects of ATR on OxPhos show that ATR incrementally 
inhibited ANT. The variable responses between ISO and ATR suggested 
and supported our previous observation that ISO does not have an 
appreciable effect on ANT activity. 
3.3. Effect of isoflurane vs. respiratory inhibitors on 
mitochondrial O2 consumption 
Time-dependent effects of DMSO (vehicle) and graded 
concentrations of ISO, complex I (ROT), or complex III (AA) inhibitors 
on O2 consumption rate in the presence of PM or SUC during states 2, 
3 and 4 respirations are shown in Fig. 5A–F. The insets show 
summaries of treatment effects on state 3 and state 4. With the 
complex I substrate PM, ISO significantly slowed state 3 respiration 
rate in a concentration-dependent manner: 183 ± 7 (0.5 mM ISO), 
106 ± 8 (1 mM ISO), and 91 ± 8 (2 mM ISO) vs. 220 ± 6 (DMSO) 
nmol·min− 1·mg− 1(Fig. 5A inset), with small decreases in state 4 
respiration: 59 ± 7 (0.5 mM ISO), 44 ± 8 (1 mM ISO), and 32 ± 7 
(2 mM ISO) vs. 32 ± 6 (DMSO) nmol·min− 1·mg− 1 (Fig. 5A inset). ISO 
also prolonged the duration of state 3 respiration: 23 ± 4 s, 40 ± 6 s 
and 49 ± 5 s at 0.5, 1 and 2 mM ISO, respectively, vs. 21 ± 6 s with 
DMSO. Like ISO, low concentrations of ROT also caused concentration-
dependent decreases in respiration and increases in state 3 duration 
(Fig. 5B). These results are consistent with the effects of ISO and ROT 
to decrease the magnitude and to increase the duration of NADH 
oxidation (Fig. 2A,B). Unlike ISO and ROT, AA (in high concentrations) 
with the substrate PM, caused a slight but significant decrease in 
respiration rate (Fig. 5C inset) and duration of state 3 (Fig. 5C), which 
are consistent with the small increases in the duration of state 3 NADH 
oxidation and ΔΨm depolarization (Figs. 2C and 3C). 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biochimica et Biophysica Acta: Bioenergetics, Vol 1837, No. 3 (March 2014): pg. 354-365. DOI. This article is © Elsevier 
and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant 
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from 
Elsevier. 
17 
 
 
Fig. 5.  Mitochondrial O2 concentration (nmol·min− 1) during states 2, 3 and 4 
respiration with different substrates and either ISO or a blocker of ETC complexes. 
ISO, ROT, or AA was added after PM (A–C) or SUC (D–F) and before ADP. Adding ADP 
induced a transient depolarization. The insets summarize effects of added ISO, ROT 
and AA on state 3 and state 4 respiration rates (nmol·min− 1·mg− 1protein). Note 
similarities and differences of responses to each drug. Data represent mean ± SD of 3 
replicates. 
ISO did not significantly decrease state 3 respiration rate in a 
concentration-dependent manner with complex II substrate SUC 
(Fig. 5D). Unlike with the substrate PM, with substrate SUC, ISO 
decreased state 3 duration: 63 ± 7 s, 60 ± 6 s and 59 ± 5 s at 0.5, 1 
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and 2 mM ISO, respectively, vs.73 ± 4 s with DMSO. The effects of 
ISO with substrate SUC (Fig. 5D) were compared with those of ROT 
(Fig. 5E) and AA (Fig. 5F). In a concentration-dependent manner, ISO 
decreased state 4 respiration rate, possibly by inhibiting complex I 
with attenuation of RET from the reduced Q pool to complex I. The 
effect of ISO to decrease state 4 respiration with substrate SUC was 
again shown to result from attenuated complex I activity because 
these results were consistent with the effect of ROT to decrease state 
4 respiration (Fig. 2 D,E). Unlike ISO, adding AA (at higher 
concentrations) caused an increase in state 3 respiration compared to 
DMSO (Fig. 5D vs. F). The effects of ISO, ROT, and AA on 
concentration-dependent changes in the duration of state 3 respiration 
showed that responses to ISO closely matched those of ROT with SUC 
as the substrate (Fig. 5D,E,F). 
The effects of ISO and AA on respiration rates with SUC as the 
substrate after complete block of complex I with high ROT (1 μM) were 
compared (Fig. 6A,B) as was done for ΔΨm (Fig. 4A,B). ISO slightly, 
but significantly, increased state 3 respiration: 120 ± 5 (DMSO), 
128 ± 7 (0.5 ISO), 139 ± 6 (1 mM ISO) and 136 ± 7 (2 mM ISO) 
nmol·min− 1·mg− 1; ISO induced a small but significant increase in state 
4 respiration. In contrast, AA induced more pronounced increases in 
state 3 respiration: 120 ± 8 (DMSO), 228 ± 8 (10 nM AA), 210 ± 8 
(20 nM AA) and 213 ± 1 (25 nM AA) nmol·min− 1·mg− 1. AA also 
increased state 4 respiration: 93 ± 8 (DMSO) 133 ± 6 (10 nM AA), 
127 ± 7 (20 nM AA), 115 ± 7 (25 nM AA) nmol·min− 1·mg− 1 that could 
be attributed to electron leak at the inhibited complex III site. Thus, 
when complex I was completely blocked, electron transfer from 
complex II to complex IV became attenuated as complex III was step-
wise blocked. With blocked proton pumping at complex I and reduced 
proton pumping at complexes III and IV, this tended to reduce the 
redox state and ΔΨm (Fig. 4A,B), thus stimulating respiration. During 
state 3 respiration with proton influx at complex V, respiration became 
even faster until ΔΨm was restored. 
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Fig. 6.  Mitochondrial O2 concentration (nmol·min− 1) during states 2, 3 and 4 
respiration with substrate SUC and either ISO or a blocker (AA) of ETC complexes. ROT 
(1 μM) was given before succinate to maximally block complex I and RET. The insets 
summarize effects of added ISO, ROT, and AA on state 3 and state 4 respiration rates 
(nmol·min− 1·mg− 1protein). Note similarities and differences of responses to each drug. 
Data represent mean ± SD of 3 replicates. 
4. Discussion 
The mitochondrion has emerged as a key component in VA-
mediated cardioprotection against IR injury. VAs (e.g. ISO) could 
provide cellular protection against IR injury, in part, by direct effects on 
mitochondrial ETC. complexes or on other proteins (ANT) involved in 
OxPhos that result in attenuated mitochondrial damage. Prior reports 
indicate that VAs likely have depressant effects on mitochondrial 
function [34], [35] and [36]. However, the specific targets and 
mechanisms of VA action on mitochondrial respiration and 
phosphorylation remain to be understood. 
The aim of this study was to identify and characterize potential 
targets of ISO in isolated cardiac mitochondria by monitoring changes 
in bioenergetic variables (NADH, ΔΨm, and respiration) during states 2, 
3 and 4 respiration. To do so we used different substrates (PM, SUC, 
SUC + ROT) in the absence and presence of ISO to compare its effects 
with ETC complex inhibitors (ROT, AA, MAL, KCN and OMN) or the ANT 
inhibitor ATR, each given in ascending submaximal concentrations. 
Overall, we found that ISO caused concentration-dependent differential 
modulation of mitochondrial NADH, ΔΨm, and respiration under different 
substrate conditions. Based on the responses and comparisons of ISO 
and classical ETC inhibitors (Fig. 1) on different states of respiration, we 
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concluded that complex I and complex III are specific respiratory protein 
targets of ISO by comparing the bioenergetic effects of ISO with those 
of classical inhibitors. In contrast, using the same approach, our data 
suggests that ISO does not significantly impair the function of 
complexes II, IV, V or ANT. The differential modulation of mitochondrial 
function under different substrate conditions with ISO provides insights 
into the more or less selective interaction of ISO with mitochondrial 
proteins. These targets could have significant implications for the 
mechanism of VA-induced protection against cardiac oxidative stress 
and could also account, in part, for the mild negative inotropic effect of 
VA's. 
4.1. Isoflurane-induced differential modulation of 
bioenergetics with substrate PM 
Transient NADH oxidation to NAD+ during ADP-stimulated 
respiration is due to a transient decrease in NADH secondary to 
enhanced proton pumping and electron transfer to replace proton influx 
via complex V (see Fig. 1). ISO and ROT exhibited very similar effects 
to attenuate the magnitude and increase the duration of state 3 NADH 
oxidation (Fig. 2A,B and insets). These effects are likely due to 
restricted proton pumping by complex I so that proton entry into 
complex V after adding ADP is slowed and prolonged. The ISO-induced 
concentration-dependent decreases in NADH oxidation and increases in 
state 3 NADH duration suggested that ISO attenuates the increases in 
electron transfer and proton pumping induced by proton influx driven 
ADP phosphorylation (Fig. 7A); these data were consistent with our 
previous observation of partial inhibition of complex I by ISO [8]. The 
low concentrations of ROT (20–80 nM), to mimic the effects of ISO, are 
believed to partially block electron transfer (and so proton pumping) 
between the NADH binding site via FeS centers and the Q binding site 
in complex I. Although we deduced that ISO attenuates complex I 
function in a similar manner, the concentrations of ISO required to 
produce the same effect on complex I are about 103 higher; this may 
indicate that the potency of ISO for an effect on the Q binding site of 
complex I is very low or that the molecular mechanism of inhibition on 
complex I is dissimilar (less specific) from that of ROT. For example, 
although ROT, like ISO, increased the duration of state 3 ΔΨm 
depolarization (Fig. 3A,B), ISO did not change the extent/magnitude of 
depolarization, whereas ROT increased it substantially. These 
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differential effects on the extent of maximal state 3 ΔΨm depolarization 
and NADH oxidation by ISO and ROT appears to imply that ISO 
attenuated complex I function somewhat differently than ROT. For 
example, the ISO-induced increase in the duration of ADP 
phosphorylation is most likely due to attenuation of proton pumping 
downstream of complex I to better match the slower rates of electron 
transfer and ADP phosphorylation due to inhibition of the complex. This 
implies that ISO may have effects other than on complex I only. 
 
Fig. 7.  Schema depicting ADP-induced changes in magnitude and duration of 
mitochondrial bioenergetic variables (NADH, ΔΨm, respiration), and presumed changes 
in electron transfer activity (ETA) along the ETC before and after ISO. ISO is compared 
with ROT or AA to induce attenuation of complex I and complex III with NAD-linked 
substrate PM (A), FAD-linked substrate SUC (B), and substrate SUC + ROT after 
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complete inhibition of complex I with 1 μM ROT (C). Small arrows ( ) indicate the 
relative number of electrons transported during FET before and after attenuation of 
complex I or complex III. Broken arrows ( ) near complex I (CI) and complex III 
(CIII) indicate mild inhibition of complexes and the solid arrow ( ) near complex I 
indicates complete inhibition of complex I with ROT (1 μM). Complexes I–IV (CI–IV); 
PM, K+-pyruvate/malate; SUC, K+-succinate; ISO, isoflurane; ROT, rotenone; AA, 
antimycin A; FET, forward electron transfer; RET, reverse electron transfer. 
ISO, like the complex III Qi site inhibitor AA [37], [38] and [39], 
increased the duration of state 3 ΔΨm (Fig. 3A,C) implying that ISO 
may attenuate complex III in addition to complex I. On the other 
hand, ISO increased the duration of state 3 ΔΨm more than AA 
(Fig. 3A,C). AA and ROT similarly prolonged the duration of state 3 
ΔΨm (Fig. 3B,C) but did not exactly match the effect of ISO (Fig. 3A), 
which again implicates complex III as another site of ISO action. The 
ISO and AA-induced increases in duration of ADP phosphorylation most 
likely result from attenuated proton pumping at complexes III and IV 
downstream of complex I due to attenuated rates of electron transfer. 
Note that because ISO appears to simultaneously inhibit complexes I 
and III, the greater state 3 durations of NADH oxidation and ΔΨm 
depolarization by ISO vs. AA may be due to ISO additionally inhibiting 
complex I. 
The net effect of proton influx at complex V with addition of ADP 
(Fig. 1) is to temporarily depolarize the IMM and consume NADH as 
respiration is enhanced to restore the ΔΨm and NADH (reducing 
equivalents). ISO, ROT, and AA each slowed state 3 respiration 
(Fig. 5A,B,C), presumably because of reduced electron transfer to 
complex IV associated with decreased proton pumping at complexes I 
and III. These results extend previous findings [8] and [23] that 
suggested that the prolonged duration of state 3 ADP phosphorylation 
can be attributed to slowed rates of electron transfer and proton 
pumping by NADH-linked intermediates; this is consistent with the 
increased duration of state 3 NADH, ΔΨm, and respiration with the 
complex I substrate PM. 
A decrease in ΔΨm can be caused by any protonophoric effect 
that would allow ADP-independent influx of protons into the matrix 
(proton leak) [40] and [41], which would increase respiration to 
restore ΔΨm. We did not observe any ISO-mediated change in matrix 
pH with BCECF-AM incubated mitochondria (data not shown), nor any 
increase in state 2 respiration to support a proton leak (Fig. 5A). 
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Indeed, during respiratory states 3 and 4 ISO slowed the rate of 
respiration, which is not consistent with a proton leak (Fig. 5A). 
A description of FET under these substrate conditions with ISO, 
ROT, and AA is depicted in Fig. 1 and Fig. 7A. We postulate that the 
mild inhibition of complex I with ROT or ISO decreases the NADH-
supported transfer of electrons in the forward direction, i.e. from 
complex I to complex III and to complex IV, and this results in 
decreased ADP-induced NADH oxidation and increased state 3 
durations of NADH oxidation, ΔΨm and respiration. The mild inhibition 
of complex III with AA or ISO decreases transfer of electrons from 
complex III to complex IV and this results in an increased duration of 
state 3 ΔΨm depolarization, without affecting the magnitude of NADH 
oxidation (Figs. 2C and 7A). 
4.2. Isoflurane-induced differential modulation of 
bioenergetics with substrate SUC 
The complex II substrate (SUC) causes a reversal of the 
standard reduction potential [25] so that NAD+ is reduced to NADH 
through RET and this causes superoxide generation at complex I 
[40] and [42]. Under these conditions ISO and ROT similarly 
decreased the extent and duration of ADP-induced state 3 NADH 
oxidation (Fig. 2D,E) and ΔΨm depolarization (Fig. 3D,E). These effects 
resulted from a decreased rate of ADP phosphorylation because the 
rate of state 3 respiration was actually slower with ISO and ROT 
(Fig. 5 D,E). A description of slowed FET under these substrate 
conditions with ISO, ROT or AA is depicted in Fig. 7B. Succinate can 
generate NADH in complex I through RET, which is sensitive to 
ΔΨm[43]. We interpret from our findings that mild inhibition of 
complex I with ISO or ROT decreased RET supported generation of 
NADH and subsequent oxidation of the available NADH resulted in 
depressed state 3 respiration. The reduced extent and duration of 
state 3 by ISO or ROT could be attributed to decreased RET-mediated 
NADH generation and impaired oxidation of NADH due to attenuated 
complex I function. However, this may not be a major contributing 
factor since RET may be less favorable when Ψm is depolarized by the 
added ADP. Therefore, an alternative possibility could be that impaired 
oxidation of NADH induced by ISO and ROT could lead to a slowing of 
the TCA cycle activity, thereby leading to accumulation of 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Biochimica et Biophysica Acta: Bioenergetics, Vol 1837, No. 3 (March 2014): pg. 354-365. DOI. This article is © Elsevier 
and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant 
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from 
Elsevier. 
24 
 
oxaloacetate, which inhibits complex II. Inhibition of complex II would 
lead to a decrease in OxPhos capacity with SUC by lowering the ΔΨm 
to result in a decrease in ROS production via oxidation of the 
ubiquinone pool [44]. A description of slowed FET under these 
substrate conditions with ISO, ROT and AA is depicted in Fig. 7B. 
ISO or ROT-induced decreases in the extent and duration of 
state 3 ΔΨm depolarization (Fig. 3 D,E) by attenuation of complex I at 
the Q site would result in decreased NADH oxidation. The net result 
would be an increase in reduced NADH and a shorter duration of NADH 
oxidation, but decreases in states 3 and 4 respiration (Fig. 5D,E 
insets). With the substrate PM, unlike the substrate SUC, the ISO-
induced increase in duration of state 3 NADH oxidation support 
inhibition of electron transfer from complex I. However, with the 
substrate SUC, the marked decreases in the duration of state 3 ΔΨm 
depolarization are more likely attributed either to a decrease in FET 
from the reduced Q site of complex I to the Q pool, or to attenuation 
of SUC-supported transfer of electrons from complex II by 
oxaloacetate accumulation. The accumulation of oxaloacetate could 
result from the inhibitory effect of ROT/ISO to reduce oxidation of 
NADH during state 3 (Fig. 8). This ISO concentration-dependent effect 
to decrease state 3 respiration diminishes the possibility that this is 
due to blocking complex I electron transfer from the Q pool to complex 
I or to attenuation of the redox between Q and QH; thus this effect 
favors the possibility of attenuation in FET along the ETC as depicted in 
Fig. 8. Moreover, because ISO or ROT depressed state 3 and state 4 
respiration with the substrate SUC (Fig. 5D,E), this verifies that ISO 
and ROT mediated attenuation of complex I function did not lead to an 
increase in respiration as a result of proton leak at the inhibited 
complex I. In mitochondria respiring on SUC, the increases in duration 
of state 3 ΔΨm depolarization (Fig. 3F) after treatment with AA could 
occur by impeding electron transfer from the SUC-driven reduced Q 
pool to complex III. 
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Fig. 8.  Schema depicting electron transfer from substrate SUC to downstream and 
upstream complex I and complex III, respectively. Electrons from SUC pass through 
FADH2 to the Q pool, which transfers electrons to the Q site of complex I. Within 
complex I, electrons transferred to the Q site can either go in the reverse direction via 
RET through FeS clusters and FMN to generate NADH from NAD+ or go in the forward 
direction via FET to produce QH2; RET vs. FET is dependent on the standard reduction 
potential across complex I. Binding of ISO, like ROT, may inhibit the transfer of 
electrons from the QH2 of complex I to the Q pool to complex III. Solid arrows ( ) 
show electrons transported in the forward direction (FET) and broken arrows ( ) 
show electrons transported in the reverse direction (RET). Question marks (?) show 
the possible indirect mechanisms of attenuation in FET either via attenuation of 
electron transfer from the Q site of complex I to the Q pool, or succinate generated 
accumulation of oxaloacetate due to ROT/ISO mediated decrease in NADH oxidation. 
4.3. Isoflurane-induced differential modulation of 
bioenergetics with substrate SUC and block of complex 
I 
ISO attenuates complex III function, as we deduced in part by 
the similarity between ISO and AA on increasing the duration of state 
3 ΔΨm depolarization with SUC after completely blocking complex I 
with 1 μM ROT (Fig. 4A,B). Attenuation of complex III function with 
inhibited FET and RET at complex I impedes FET from substrate SUC 
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and could lead to electron leak and O2− generation [25]. The apparent 
increases in states 3 and 4 respiration with SUC + ROT (Fig. 6A,B) 
could be attributed to increased O2− generation, due to electron leak at 
complex III with AA, rather than reduction of O2 to H2O [45]. The 
effects of mild inhibition of complex III with ISO or AA to decrease 
transfer of electrons from complex III to complex IV and to increase 
the duration of state 3 ΔΨm depolarization is depicted in Fig. 7C. 
We additionally explored the possibility that in the presence of 
SUC + ROT the ISO-mediated increases in duration of state 3 ΔΨm 
depolarization can be alternatively explained by an attenuating effect 
of ISO on complex II or ANT function. But unlike ISO, which increased 
the duration of ADP phosphorylation, low concentrations of ATR did not 
significantly change state 3 ΔΨm duration (Fig. 4C,D). This implies that 
ISO-mediated increases in state 3 duration are likely attributed to 
attenuation of complex III rather than to attenuation of complex II 
function or attenuation of transfer of ADP/ATP by ANT. The data 
obtained on attenuation of complex IV function by KCN (data not 
shown), and it's comparison by ISO, suggests that complex IV is also 
not a potential target of ISO. 
Because ISO induced small increases in states 2, 3, and 4 
respiration (Fig. 6A) under the substrate SUC + ROT (1 μM), we tested 
if ISO exhibited characteristics of proton leak (uncoupling) by 
comparing the effects of low titrated concentrations of known 
uncouplers (DNP, FCCP) to induce mitochondrial ΔΨm depolarization. 
Compared to ISO, these uncoupling agents caused a pronounced state 
2 depolarization (data not shown). In addition, matrix acidification and 
ΔΨm depolarization are hallmarks of proton leak [41] and [46], but we 
did not observe any change in matrix pH measured by BCECF 
fluorescence (data not shown). 
4.4. Isoflurane-induced effects on complexes I and III: 
implication for cardioprotection 
Volatile anesthetics protect the myocardium against IR injury, in 
part, by modulating mitochondrial respiratory function [47], 
[48] and [49] to mildly disrupt electron transfer and induce small 
amount of ROS, which acts as a signaling molecule [11], [18], 
[33] and [35]. In this current study, we concentrated on identifying 
the direct effects of ISO on proteins involved in mitochondrial 
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respiration, nucleotide transfer and OxPhos with the aim to better 
understand how VAs modulate cardiac function and confer protection 
against IR injury. 
We proposed that ISO-mediated cardioprotection is initiated by 
partial inhibition of at least several ETC protein components to cause 
decreased electron transport and induce ROS production, which in turn 
initiates cardioprotective pathways. Based on this and prior studies, we 
believe it is plausible that ISO protects by attenuating complex I and 
complex III activity to cause 1) release of small amounts of ROS at 
complex I [50], [51] and [52] and complex III [53] and [54] during 
the period before ischemia (APC) or after ischemia (APOC), and 2) 
decrease in O2 consumption by reducing the workload during the 
period of limited O2 availability during ischemia [55]. These events 
could limit deleterious ROS generation during IR and so prevent 
mitochondria from initiating apoptotic events leading to cell death. We 
showed previously that limiting complex I activity during ischemia has 
the potential to minimize accumulation of ROS on reperfusion and 
therefore to protect mitochondria and the cell from oxidative damage 
[19]. 
Notably, both complex I and complex III are targets but also 
sites of ROS generation [45], [56] and [57]. The cardioprotective 
effect of ISO against IR injury could also be triggered by a small rise in 
ROS by its selective inhibition of ETC activity at complex I [50], 
[51] and [52] and complex III [53] and [54]. Our study provides 
useful information on effects of ISO on forward and backward electron 
transfer pathways that modulate mitochondrial bioenergetics in a way 
that may contribute to cardioprotection. 
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